{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:55:01Z","timestamp":1793145301037,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.phrs.2026.108219","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T07:05:15Z","timestamp":1777359915000},"page":"108219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Microbiota-targeted nanoplatforms for colorectal cancer immunotherapy"],"prefix":"10.1016","volume":"228","author":[{"given":"Shu-Qiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Nan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Dong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.phrs.2026.108219_bib1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"9-10","key":"10.1016\/j.phrs.2026.108219_bib2","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s12272-025-01570-0","article-title":"Histone lactylation in gastrointestinal cancers: developing immunotherapeutic drugs targeting epigenetics","volume":"48","author":"Huang","year":"2025","journal-title":"Arch. Pharm. Res."},{"issue":"3","key":"10.1016\/j.phrs.2026.108219_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.chom.2014.02.007","article-title":"Microbes, microbiota, and colon cancer","volume":"15","author":"Sears","year":"2014","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10.1016\/j.phrs.2026.108219_bib4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","article-title":"Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/beta-catenin signaling via its FadA adhesin","volume":"14","author":"Rubinstein","year":"2013","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10.1016\/j.phrs.2026.108219_bib5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/cid\/ciu787","article-title":"The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients","volume":"60","author":"Boleij","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.phrs.2026.108219_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.chom.2013.07.007","article-title":"Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment","volume":"14","author":"Kostic","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.phrs.2026.108219_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107726","article-title":"Gut microbiota reshapes the TNBC immune microenvironment: Emerging immunotherapeutic strategies","volume":"215","author":"Huang","year":"2025","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.phrs.2026.108219_bib8","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2486519","article-title":"Gut microbiota in hepatocellular carcinoma immunotherapy: immune microenvironment remodeling and gut microbiota modification","volume":"17","author":"Huang","year":"2025","journal-title":"Gut Microbes"},{"issue":"5","key":"10.1016\/j.phrs.2026.108219_bib9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nri2515","article-title":"The gut microbiota shapes intestinal immune responses during health and disease","volume":"9","author":"Round","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"6086","key":"10.1016\/j.phrs.2026.108219_bib10","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1126\/science.1223490","article-title":"Interactions between the microbiota and the immune system","volume":"336","author":"Hooper","year":"2012","journal-title":"Science"},{"issue":"7480","key":"10.1016\/j.phrs.2026.108219_bib11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.phrs.2026.108219_bib12","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","article-title":"Gut microbiota regulation of tryptophan metabolism in health and disease","volume":"23","author":"Agus","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/j.phrs.2026.108219_bib13","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MOG.0000000000000057","article-title":"Bile acids and the gut microbiome","volume":"30","author":"Ridlon","year":"2014","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.phrs.2026.108219_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1119992","article-title":"Role of gut microbiota and bacterial metabolites in mucins of colorectal cancer","volume":"13","author":"Gu","year":"2023","journal-title":"Front. Cell Infect. Microbiol."},{"issue":"23","key":"10.1016\/j.phrs.2026.108219_bib15","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability-high advanced colorectal cancer","volume":"383","author":"Andre","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"6264","key":"10.1016\/j.phrs.2026.108219_bib16","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"Vetizou","year":"2015","journal-title":"Science"},{"issue":"6371","key":"10.1016\/j.phrs.2026.108219_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"issue":"6371","key":"10.1016\/j.phrs.2026.108219_bib18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.aao3290","article-title":"The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients","volume":"359","author":"Matson","year":"2018","journal-title":"Science"},{"issue":"6529","key":"10.1016\/j.phrs.2026.108219_bib19","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.phrs.2026.108219_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.phrs.2026.108219_bib21","article-title":"Interactions of nanomaterials with gut microbiota and their applications in cancer therapy","volume":"23","author":"Li","year":"2023","journal-title":"Sens. (Basel)"},{"key":"10.1016\/j.phrs.2026.108219_bib22","article-title":"Synergistic effect of nanoparticles with probiotics on gastrointestinal regenerative medicine","author":"Kouhbananinejad","year":"2025","journal-title":"Probiotics Antimicrob. Proteins"},{"issue":"20","key":"10.1016\/j.phrs.2026.108219_bib23","doi-asserted-by":"crossref","first-page":"12917","DOI":"10.1021\/acsnano.4c00830","article-title":"Polyphenolic nanoparticle-modified probiotics for microenvironment remodeling and targeted therapy of inflammatory bowel disease","volume":"18","author":"Hu","year":"2024","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.phrs.2026.108219_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/cai2.150","article-title":"Impact of metallic nanoparticles on gut microbiota modulation in colorectal cancer: a review","volume":"3","author":"Kumar","year":"2024","journal-title":"Cancer Innov."},{"issue":"46","key":"10.1016\/j.phrs.2026.108219_bib25","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.3748\/wjg.v28.i46.6497","article-title":"Nanotechnology for colorectal cancer detection and treatment","volume":"28","author":"Gogoi","year":"2022","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108219_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens14050509","article-title":"Bacteria and carcinogenesis and the management of cancer: a narrative review","volume":"14","author":"Plewa","year":"2025","journal-title":"Pathogens"},{"key":"10.1016\/j.phrs.2026.108219_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharm. Ther."},{"issue":"2","key":"10.1016\/j.phrs.2026.108219_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71575","article-title":"Crosstalk between intratumoral microbes and tumor immunity: implications for tumor therapy","volume":"15","author":"Li","year":"2026","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.phrs.2026.108219_bib29","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/s41564-024-01695-w","article-title":"Peptostreptococcus anaerobius mediates anti-PD1 therapy resistance and exacerbates colorectal cancer via myeloid-derived suppressor cells in mice","volume":"9","author":"Liu","year":"2024","journal-title":"Nat. Microbiol"},{"issue":"7937","key":"10.1016\/j.phrs.2026.108219_bib30","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","article-title":"Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer","volume":"611","author":"Galeano Nino","year":"2022","journal-title":"Nature"},{"issue":"31","key":"10.1016\/j.phrs.2026.108219_bib31","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1038\/s41388-024-03080-7","article-title":"Tumor-resident microbiota contributes to colorectal cancer liver metastasis by lactylation and immune modulation","volume":"43","author":"Gu","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2026.108219_bib32","article-title":"The role of Fusobacterium nucleatum in macrophage M2 polarization and NF-kappaB pathway activation in colorectal cancer","volume":"16","author":"Zheng","year":"2025","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2026.108219_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112610","article-title":"Jianpi Jiedu decoction suppresses colorectal cancer growth by inhibiting M2 polarization of TAMs through the tryptophan metabolism-AhR pathway","volume":"138","author":"Chang","year":"2024","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108219_bib34","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2442037","article-title":"Fusobacterium nucleatum-driven CX3CR1(+) PD-L1(+) phagocytes route to tumor tissues and reshape tumor microenvironment","volume":"17","author":"Chen","year":"2025","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.phrs.2026.108219_bib35","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2449111","article-title":"Lactobacillus intestinalis facilitates tumor-derived CCL5 to recruit dendritic cell and suppress colorectal tumorigenesis","volume":"17","author":"Sun","year":"2025","journal-title":"Gut Microbes"},{"issue":"3","key":"10.1016\/j.phrs.2026.108219_bib36","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.chom.2023.01.013","article-title":"Tissue-resident Lachnospiraceae family bacteria protect against colorectal carcinogenesis by promoting tumor immune surveillance","volume":"31","author":"Zhang","year":"2023","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.phrs.2026.108219_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s43556-024-00200-3","article-title":"Gut microbiome influences efficacy of Endostatin combined with PD-1 blockade against colorectal cancer","volume":"5","author":"Xu","year":"2024","journal-title":"Mol. Biomed."},{"issue":"10","key":"10.1016\/j.phrs.2026.108219_bib38","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1136\/gutjnl-2025-335306","article-title":"Bacteria-metabolite butyrate boosts anti-PD1 efficacy in colorectal cancer patient-derived organoids through activating autologous tumour-infiltrating GNLY (+)CD8(+) T cells","volume":"74","author":"Zhang","year":"2025","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.phrs.2026.108219_bib39","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1016\/j.immuni.2021.11.003","article-title":"Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer","volume":"54","author":"Overacre-Delgoffe","year":"2021","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.phrs.2026.108219_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277155","article-title":"Probiotic powder ameliorates colorectal cancer by regulating Bifidobacterium animalis, Clostridium cocleatum, and immune cell composition","volume":"18","author":"Yang","year":"2023","journal-title":"PLoS One"},{"issue":"46","key":"10.1016\/j.phrs.2026.108219_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202512744","article-title":"An engineered probiotic consortium based on quorum-sensing for colorectal cancer immunotherapy","volume":"12","author":"Guo","year":"2025","journal-title":"Adv. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2026.108219_bib42","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/1735-5362.235156","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages","volume":"13","author":"Ghasemiyeh","year":"2018","journal-title":"Res Pharm. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2026.108219_bib43","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12951-021-00896-3","article-title":"Protein nanoparticles in drug delivery: animal protein, plant proteins and protein cages, albumin nanoparticles","volume":"19","author":"Kianfar","year":"2021","journal-title":"J. Nanobiotechnology"},{"issue":"7","key":"10.1016\/j.phrs.2026.108219_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202410011","article-title":"Nano-armed limosilactobacillus reuteri for enhanced photo-immunotherapy and microbiota tryptophan metabolism against colorectal cancer","volume":"12","author":"Xu","year":"2025","journal-title":"Adv. Sci."},{"issue":"12","key":"10.1016\/j.phrs.2026.108219_bib45","doi-asserted-by":"crossref","first-page":"11466","DOI":"10.1021\/acsnano.3c01308","article-title":"Modulation of intratumoral fusobacterium nucleatum to enhance sonodynamic therapy for colorectal cancer with reduced phototoxic skin injury","volume":"17","author":"Qu","year":"2023","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.phrs.2026.108219_bib46","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1021\/acsnano.3c11436","article-title":"An oral nanomedicine elicits in situ vaccination effect against colorectal cancer","volume":"18","author":"Zu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.phrs.2026.108219_bib47","doi-asserted-by":"crossref","DOI":"10.1177\/15330338231160391","article-title":"Biocompatible polymer nano-constructs: a potent platform for cancer theranostics","volume":"22","author":"Kalita","year":"2023","journal-title":"Technol. Cancer Res Treat."},{"issue":"8","key":"10.1016\/j.phrs.2026.108219_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202200474","article-title":"Trends in the synthesis of polymer nano- and microscale materials for bio-related applications","volume":"23","author":"Coats","year":"2023","journal-title":"Macromol. Biosci."},{"issue":"3","key":"10.1016\/j.phrs.2026.108219_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/polym17030412","article-title":"Inulin as a biopolymer; chemical structure, anticancer effects, nutraceutical potential and industrial applications: a comprehensive review","volume":"17","author":"Karimi","year":"2025","journal-title":"Polymers"},{"issue":"46","key":"10.1016\/j.phrs.2026.108219_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202407685","article-title":"Inulin-based nanoparticle modulates gut microbiota and immune microenvironment for improving colorectal cancer therapy","volume":"34","author":"Zhu","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.phrs.2026.108219_bib51","article-title":"Orally administrated hydrogel harnessing intratumoral microbiome and microbiota-related immune responses for potentiated colorectal cancer treatment","volume":"7","author":"Li","year":"2024","journal-title":"Research"},{"key":"10.1016\/j.phrs.2026.108219_bib52","article-title":"Oral microbiota-responsive ZIF nanoplatform via double-layer glycans modified combined with PD-1 inhibitor for treatment of microsatellite-stable colorectal cancer","volume":"35","author":"Sun","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"6","key":"10.1016\/j.phrs.2026.108219_bib53","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s42114-025-01492-x","article-title":"Microbiota-responsive oral nano-amifostine enables colorectal-specific radioprotection and tumor immunity via gut microenvironment reprogramming","volume":"8","author":"Song","year":"2025","journal-title":"Adv. Compos Hybrid. Mater."},{"issue":"1","key":"10.1016\/j.phrs.2026.108219_bib54","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1038\/s41467-023-40439-y","article-title":"Combining gut microbiota modulation and chemotherapy by capecitabine-loaded prebiotic nanoparticle improves colorectal cancer therapy","volume":"14","author":"Lang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108219_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2024.108509","article-title":"Advanced technological approaches and market status analysis of xylose bioconversion and utilization: Xylooligosacharides and xylonic acid as emerging products","volume":"79","author":"Han","year":"2025","journal-title":"Biotechnol. Adv."},{"issue":"1","key":"10.1016\/j.phrs.2026.108219_bib56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1039\/D1CS00804H","article-title":"Post-synthetic modifications in porous organic polymers for biomedical and related applications","volume":"51","author":"Kim","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"20","key":"10.1016\/j.phrs.2026.108219_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1590","article-title":"Bioinorganic hybrid bacteriophage for modulation of intestinal microbiota to remodel tumor-immune microenvironment against colorectal cancer","volume":"6","author":"Dong","year":"2020","journal-title":"Sci. Adv."},{"issue":"41","key":"10.1016\/j.phrs.2026.108219_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202402164","article-title":"Flying-saucer-shaped nanoheterojunctions with enhanced colorectal tumor accumulation for increased oxidative stress and immunometabolic regulation","volume":"34","author":"Ma","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.phrs.2026.108219_bib59","article-title":"Targeting Peptostreptococcus anaerobius with an iron-based nanozyme reverses ferroptosis resistance and enhances antitumor immunity in colorectal cancer","author":"Cao","year":"2026","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2026.108219_bib60","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2026.2624186","article-title":"Unlocking the potential of mesoporous silica nanoparticles: balancing biomedical applications and safety concerns","volume":"33","author":"Hou","year":"2026","journal-title":"Drug Deliv."},{"key":"10.1016\/j.phrs.2026.108219_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122530","article-title":"Magnetic natural lipid nanoparticles for oral treatment of colorectal cancer through potentiated antitumor immunity and microbiota metabolite regulation","volume":"307","author":"Li","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2026.108219_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101329","article-title":"Combination gut microbiota modulation and chemotherapy for orthotopic colorectal cancer therapy","volume":"41","author":"Chen","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.phrs.2026.108219_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114512","article-title":"Nanoprodrug targeting tumor-associated intracellular bacteria enhances colorectal cancer immunotherapy","volume":"390","author":"Yu","year":"2026","journal-title":"J. Control Release"},{"issue":"2","key":"10.1016\/j.phrs.2026.108219_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/INMD.20240103","article-title":"Regulating gut microbiota with nanomaterials for cancer immunotherapy","volume":"3","author":"Sha","year":"2025","journal-title":"Interdiscip. Med."},{"key":"10.1016\/j.phrs.2026.108219_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1680838","article-title":"Combination of PD-1\/PD-L1 and CTLA-4 inhibitors in the treatment of cancer - a brief update","volume":"16","author":"Park","year":"2025","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2026.108219_bib66","article-title":"Exploring immune checkpoint inhibitors: focus on PD-1\/PD-L1 axis and beyond","volume":"269","author":"Aden","year":"2025","journal-title":"Pathol. Res Pr."},{"issue":"2","key":"10.1016\/j.phrs.2026.108219_bib67","doi-asserted-by":"crossref","first-page":"198","DOI":"10.17305\/bjbms.2022.8286","article-title":"Intrinsic resistance and efficacy of immunotherapy in microsatellite instability-high colorectal cancer: a systematic review and meta-analysis","volume":"23","author":"Wang","year":"2023","journal-title":"Biomol. Biomed."},{"issue":"10","key":"10.1016\/j.phrs.2026.108219_bib68","doi-asserted-by":"crossref","DOI":"10.4251\/wjgo.v17.i10.109503","article-title":"Bidirectional regulation of the gut microbiome-immune axis in the immune microenvironment of colorectal cancer and targeted interventions","volume":"17","author":"Liu","year":"2025","journal-title":"World J. Gastrointest. Oncol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108219_bib69","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41591-022-01695-5","article-title":"Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma","volume":"28","author":"Lee","year":"2022","journal-title":"Nat. Med."},{"issue":"6371","key":"10.1016\/j.phrs.2026.108219_bib70","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti\u2013PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.phrs.2026.108219_bib71","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MS9.0000000000004399","article-title":"Engineered food-borne probiotics delivering checkpoint-inhibitor modulators","volume":"88","author":"Mehmood","year":"2026","journal-title":"Ann. Med. Surg."},{"issue":"2","key":"10.1016\/j.phrs.2026.108219_bib72","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2249143","article-title":"Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell","volume":"15","author":"Zhu","year":"2023","journal-title":"Gut Microbes"},{"issue":"12","key":"10.1016\/j.phrs.2026.108219_bib73","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00692-25","article-title":"Sodium butyrate inhibits colorectal cancer development by reducing M2 macrophage polarization and PD-L1 expression","volume":"10","author":"Han","year":"2025","journal-title":"mSystems"},{"issue":"1","key":"10.1016\/j.phrs.2026.108219_bib74","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/MS9.0000000000004267","article-title":"Microbial metabolites regulating PD-L1 and checkpoint pathways: translational implications","volume":"88","author":"Mehmood","year":"2026","journal-title":"Ann. Med. Surg."},{"issue":"4","key":"10.1016\/j.phrs.2026.108219_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114086","article-title":"T cell cascade regulation initiates systemic antitumor immunity through living drug factory of anti-PD-1\/IL-12 engineered probiotics","volume":"43","author":"Liao","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2026.108219_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104595","article-title":"Central nervous system complications of immune checkpoint inhibitors: a comprehensive review","volume":"206","author":"Lopes","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108219_bib77","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12943-024-02214-5","article-title":"Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges","volume":"24","author":"Wang","year":"2025","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2026.108219_bib78","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13046-025-03396-6","article-title":"A novel pH-sensitive nanoparticles encapsulating anti-PD-1 antibody and MDK-siRNA overcome immune checkpoint blockade resistance in HCC via reshaping immunosuppressive TME","volume":"44","author":"Xu","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2026.108219_bib79","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2147\/IJN.S496873","article-title":"Enhanced cancer immunotherapy by bacterial cytoplasmic membranes coated nanovaccines for co-delivery of ovalbumin antigen and immune adjuvants to dendritic cells in lymph nodes","volume":"20","author":"Zhao","year":"2025","journal-title":"Int J. Nanomed."},{"issue":"16","key":"10.1016\/j.phrs.2026.108219_bib80","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.scib.2024.06.016","article-title":"An emerging antibacterial nanovaccine for enhanced chemotherapy by selectively eliminating tumor-colonizing bacteria","volume":"69","author":"Chen","year":"2024","journal-title":"Sci. Bull."},{"issue":"8","key":"10.1016\/j.phrs.2026.108219_bib81","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202413392","article-title":"An OMV-based nanovaccine as antigen presentation signal enhancer for cancer immunotherapy","volume":"37","author":"Lu","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phrs.2026.108219_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2025.105026","article-title":"Exploring novel strategies of oncolytic viruses and gut microbiota to enhance CAR-T cell therapy for colorectal cancer","volume":"417","author":"Yi","year":"2025","journal-title":"Cell Immunol."},{"key":"10.1016\/j.phrs.2026.108219_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1705354","article-title":"CAR-NK cell for gynecological cancers: immune microenvironment remodeling and immunotherapeutic strategies","volume":"16","author":"Huang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108219_bib84","article-title":"Clinical trials of nanoparticle-enhanced CAR-T and NK cell therapies in oncology: overcoming translational and clinical challenges - a mini review","volume":"12","author":"Zhao","year":"2025","journal-title":"Front Med."},{"key":"10.1016\/j.phrs.2026.108219_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/or.2025.1581856","article-title":"Prospects of engineered bacteria-assisted CAR T Cell therapy in gastrointestinal cancers","volume":"19","author":"Zhang","year":"2025","journal-title":"Oncol. Rev."},{"issue":"5","key":"10.1016\/j.phrs.2026.108219_bib86","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1158\/2643-3230.BCD-24-0203","article-title":"Microbiota shape metabolic and immune determinants of CAR-T therapy and correlate with outcomes in Myeloma","volume":"6","author":"Uribe-Herranz","year":"2025","journal-title":"Blood Cancer Discov."},{"issue":"2","key":"10.1016\/j.phrs.2026.108219_bib87","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1158\/1078-0432.CCR-25-1676","article-title":"The potential of the gut microbiota and butyrate to enhance CAR T-cell therapy in non-hodgkin lymphoma","volume":"32","author":"Garcia-Vicente","year":"2026","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.phrs.2026.108219_bib88","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1021\/acs.molpharmaceut.4c00264","article-title":"Lipopolysaccharide induces resistance to CAR-T cell therapy of colorectal cancer cells through TGF-beta-mediated stemness enhancement","volume":"22","author":"Tao","year":"2025","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/j.phrs.2026.108219_bib89","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1158\/2159-8290.CD-24-1230","article-title":"Gut microbiota modulation through Akkermansia spp. supplementation increases CAR T-cell potency","volume":"15","author":"Marcos-Kovandzic","year":"2025","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.phrs.2026.108219_bib90","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ymthe.2023.01.012","article-title":"Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy","volume":"31","author":"Uribe-Herranz","year":"2023","journal-title":"Mol. Ther."},{"issue":"6667","key":"10.1016\/j.phrs.2026.108219_bib91","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.add7034","article-title":"Probiotic-guided CAR-T cells for solid tumor targeting","volume":"382","author":"Vincent","year":"2023","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.phrs.2026.108219_bib92","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00262-025-04252-4","article-title":"Gut microbial metabolite butyrate boosts p53-expressing telomerase-specific oncolytic adenovirus efficacy by enhancing infectivity and activating MHC-I\/cGAS-STING","volume":"75","author":"Sakamoto","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"issue":"3","key":"10.1016\/j.phrs.2026.108219_bib93","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s41551-025-01476-8","article-title":"Engineered bacteria launch and control an oncolytic virus","volume":"10","author":"Singer","year":"2026","journal-title":"Nat. Biomed. Eng."},{"issue":"9","key":"10.1016\/j.phrs.2026.108219_bib94","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.tcb.2024.11.010","article-title":"Harnessing nanoengineered CAR-T cell strategies to advance solid tumor immunotherapy","volume":"35","author":"Wang","year":"2025","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.phrs.2026.108219_bib95","article-title":"A tumor cell membrane-coated CD40 ligand-encoding oncolytic adenovirus serves as a potent nano-vaccine for ovarian cancer immunotherapy","author":"Li","year":"2026","journal-title":"Adv. Health Mater."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826001349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826001349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T11:16:30Z","timestamp":1780139790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826001349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":95,"alternative-id":["S1043661826001349"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108219","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbiota-targeted nanoplatforms for colorectal cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108219"}}